; more recently, its over-expression has been shown to protect cells from apoptosis in the mitochondrial pathway. 20) Some biochemical studies suggest that Bcl-2 can function both as an ion channel and an adapter or docking protein in the mitochondria 21) or endoplasmic reticulum. 22) Although the detailed function of Bcl-2 in the mitochondria is still obscure, it may inhibit a voltage-dependent anion channel (VDAC). 23) The VDAC may work as a proton pump in response to BH-3-only proteins (e.g., Bax, Bim) to release cytochrome c from the mitochondria. 24, 25) Recently, however, several studies have shown that the over-expression of Bcl-2 does not rescue cells from death in some apoptotic pathways. [26] [27] [28] These suggest the existence of complicated and unknown apoptotic pathways.
We previously reported that a morphine-derived analgesic, buprenorphine hydrochloride (Bph), induced apoptosis in NG108-15 cells. 29, 30) NG108-15 is a rodent neuroblastomaϫ glioma hybrid cell line. It was generated by Nelson et al. 31) in 1976 and has been widely used as an experimental material in pharmacology. In our previous paper, 30) we reported that caspase-3 is activated in this particular apoptosis; however, the detailed apoptotic pathway was still unclear.
In this report, we focused on revealing the details of the Bph-induced apoptotic pathway in NG108-15 cells and show that the mitochondrion is the key organelle in the promotion of this rapid apoptosis. However, the prominent finding was that this particular apoptosis was not suppressed in an NG108-15 transformant that overexpressed Bcl-2.
MATERIALS AND METHODS

Cells and Culture
The NG108-15 cell line used in this study is a rodent-derived neuroblastomaϫglioma hybrid line established by Nelson et al. 31) The Bcl-2(P2) cell line is a stable NG108-15 cell transfectant bearing the human Bcl-2 expression vector (pCAGGS bcl-2; a gift from professor Yoshihide Tsujimoto, OSAKA University, Japan). Both lines were routinely cultured at 37°C in Dulbecco's Modified Eagle's Medium (Nissui, Japan) supplemented with 10% fetal bovine serum (FBS), 1ϫ10 Ϫ4 M hypoxanthine, 1ϫ10 Ϫ6 M aminopterin, and 1ϫ10 Ϫ5 M thymidine (normal medium); 100 mg/ml streptomycin was added. Cells were maintained under 100% humidity with a 5% CO 2 atmosphere. In the serum-starvation condition, NG108-15 and Bcl-2(P2) cells were cultured in a 0.1% low serum (LS) medium; all of the components of the LS medium were the same as in normal medium except the FBS concentration, which was 0.1%.
Induction of Apoptosis in NG108-15 Cells and Bcl-2(P2) Cells To induce apoptosis in the NG108-15 and Bcl-2(P2) cells, either Bph was administered or the cells were subjected to serum starvation in 0.1% LS medium. For Bphinduced apoptosis, a final concentration of 100 mM Bph (dissolved in a 40% methanol solution) was added to the culture medium; 40% methanol was used as vehicle. For serum starvation, normal medium was replaced with the "0.1% LS" medium when the cells were growing logarithmically. Incubation was continued for another 4 d to induce apoptosis. Cell Viability, Morphological Observation of Apoptosis, and DNA Fragmentation Assay Cell viability was assayed by the trypan blue dye exclusion method. 30) An Olympus model IX-70 inverted phase-contrast microscope equipped with an IX-FLA fluorescence observation device was used to observe the morphological changes in NG108-15 and Bcl-2(P2) cells. Typical nuclear condensation was used as an apoptotic marker and observed using Hoechst 33258 dye (Molecular Probes, U.S.A.). An assay of DNA ladder formation over time was conducted as described previously. 29) Flow Cytometric Analysis for the Progression of the Loss of Mitochondrial Transmembrane Potential To detect changes in the mitochondrial membrane potential, we used the ApoAlert ® Mitochondrial Membrane Sensor Kit (BD Biosciences Clontech, U.S.A.) following the manufacturer's instructions. In brief, intact or apoptotic NG108-15 and Bcl-2(P2) cells were harvested, washed with ice-cold PBS (Ϫ), and prepared at a final density of 10 9 cells per ml in a flow cytometry tube. The cells were spun and resuspended in 1 ml of diluted Mitosensor ® reagent, which came with the kit. After a 15-min incubation in a CO 2 incubator, 1 ml of Incubation buffer (from the kit) was added, and the cell suspension was prepared for flow cytometry (Coulter, EPICS ® XL, U.S.A.). Aggregated Mitosensor ® dye was detected in the PI channel and monomeric Mitosensor ® was detected in the fluorescein isothiocyanate (FITC) channel.
Western Blotting To detect cytochrome c and caspase-9, intact or apoptotic NG108-15 or Bcl-2(P2) cells were harvested by trypsinization at the sampling times indicated in each figure; the cells were then washed with ice-cold PBS (Ϫ). The cell fractionation to obtain the mitochondrial and cytosolic fractions was conducted using the ApoAlert ® Cell Fractionation Kit (BD Biosciences Clontech, U.S.A.) following the manufacturer's instructions. Briefly, the cell pellet was suspended in the Cell Fractionation Buffer with protease inhibitors (all reagents were from the kit) and spun first at 700ϫg for 5 min at 4°C, then at 10000ϫg for 25 min at 4°C. The pellet obtained after the second centrifugation step was the mitochondrial fraction, and it was resuspended in the Cell Fractionation Buffer. The supernatant from the second centrifugation step was used as the cytosolic fraction.
For the western blotting of cytochrome c, 10 mg each of mitochondrial and cytosolic protein was subjected to 15% SDS-polyacrylamide gel electrophoresis (SDS-PAGE). A 10-mg aliquot of protein from the cytosolic fraction was used for the detection of capsase-9 and separated by 12.5% SDS-PAGE. Proteins were then electro-transferred to a PROT-RAN ® nitrocellulose transfer membrane (Schleicher & Schull, U.S.A.). The membrane was blocked in 10% non-fat milk in TBST buffer (20 mM Tris-HCl, 0.5 M NaCl, 0.05% Tween 20, pH 7.5) at room temperature for 1 h. The primary antibodies were as follows: rabbit anti mouse-cytochrome c antibody (diluted 1 : 100; came with the ApoAlert ® Cell Fractionation Kit, BD Biosciences Clontech), mouse anti mouse-caspase-9 antibody (diluted 1 : 100; MBL, Japan).
A 10-mg aliquot of mitochondrial protein was also subjected to 12.5% SDS-PAGE to detect the human Bcl-2 protein expressed in the mitochondria. For this purpose, we used intact NG108-15 cells, mock-vector (pCAGGS)-transfected NG108-15 cells, and Bcl-2(P2) cells as follows. The individual NG108-15 transfectants were assayed by western blotting to determine the amount of Bcl-2 expressed. The primary antibodies were a mouse anti-human Bcl-2 monoclonal antibody (diluted 1 : 200; NEO MARKERS, U.S.A.) or mouse anti-mouse Bcl-2 monoclonal antibody (diluted 1 : 500; NEO MARKERS, U.S.A.), the latter of which was used as a control to detect the intrinsic mouse Bcl-2 protein. Beta-actin antibody (diluted 1 : 5000; CHEMICON, U.S.A.) and cytochrome c oxidase subunit IV (COX4) antibody (diluted 1 : 100; BD Biosciences Clontech, U.S.A.) were used respectively to detect b-actin and COX4 as loading controls for the western blots. All the western blot procedures to detect bactin and COX4 were as described above.
Immunofluorescence Microscopy Bcl-2(P2) cells were harvested and fixed in a 3.7% formaldehyde-PBS (ϩ) solution. The collected cells were incubated in 0.1% Triton X100-PBS (ϩ). The primary antibodies (human or mouse anti-Bcl-2 monoclonal antibodies, NEO MARKERS, U.S.A.; mouse COX4 antibody, BD Biosciences Clontech, U.S.A.) were diluted 1 : 100 in 2% BSA-PBS (ϩ) and incubated with the cells at 4°C for 16 h. The FITC/rhodamine-conjugated secondary antibodies (Santa Cruz Biotechnology, U.S.A.) were used at a 1 : 100 dilution in 2% BSA-PBS (ϩ) solution, and the incubation was for 1 h at room temperature. The cells were mounted using the ProLong ® Antifade Kit (Molecular Probe, U.S.A.), and an Olympus FV-500 laser confocal microscope was used to observe the cellular localization of cytochrome c and Bcl-2.
Colorimetric Assay for Caspase-3 Activation Caspase-3 activation following treatment with 100 mM Bph in NG108-15 and Bcl-2(P2) cells was assayed using the ApoAlert ® Caspase Colorimetric Assay Kit (BD Biosciences Clontech, U.S.A.), following the manufacturer's instructions. The increase in the caspase-3 activity was determined by comparing the results with uninduced control samples; that is, we subtracted the background reading from cell lysates and buffers from the reading of the induced and uninduced cells, before calculating the fold increase in the caspase activities per mg protein per ml cell lysate.
RESULTS
The Death Signal of Bph-Induced Apoptosis is Routed through the Mitochondria One of the major death-signal transduction pathways is known to cascade from the mitochondria to caspase-3, the effector molecule. To determine the detailed signal-transduction pathway of the Bph-induced apoptosis in NG108-15 cells, we studied the contribution of several representative molecules to the mitochondrial pathway: cytochrome c, caspases-9, and -3 ( Fig. 1) .
As the first step, we measured the loss of mitochondrial membrane potential, because this loss is known usually to occur in advance of the release of cytochrome c from the mi-tochondria. 32, 33) Using flow cytometric analysis (FACS), we observed that the loss of mitochondrial membrane potential was already induced by 1 h after the administration of Bph to NG108-15 cells (Fig. 1A ). An increase in the number of FITC (ϩ) cells, which indicated the disruption of the mitochondrial membrane structure, was also seen as early as 1 h after Bph administration in NG108-15 cells. These data strongly suggested that rapid disruption of the mitochondria was initiated by the administration of Bph to NG108-15 cells.
We next investigated the release of cytochrome c from mitochondria using western blotting and found that it also started by 1 h after Bph administration to the NG108-15 cells (Fig. 1B) . In agreement with this finding, the cytochrome c concentration increased with time in the cytosolic fraction (Fig. 1B) .
Once cytochrome c is released from the mitochondria, it triggers the activation of pro-caspase-9 in cooperation with Apaf-1.
12) The activated death signal then cascades downstream to pro-caspase-3. Activated caspase-3 finally plays the important role of transmitting the death signal to a final death executor, one or more DNases such as CAD and ICAD. 34, 35) We assessed the activation of caspase-9 and -3 by western blotting and a colorimetric method, and found that the activation of these caspases started as early as 1 h after Bph-administration, and it proceeded in a time-dependent manner (Figs.  1C, D) . These results strongly suggested that the Bph-induced death signal is routed through the mitochondrial apoptotic pathway in NG108-15 cells.
Construction of Bcl-2 Stable Transfectants and the Cellular Localization of Bcl-2
The mitochondrial apoptotic pathway is usually inhibited by the over-expression of Bcl-2. 13, 18) To confirm the results obtained in Fig. 1 , we constructed stable Bcl-2-expressing NG 108-15 transfectants with a Bcl-2 expression vector, pCAGGS bcl-2, which contains the human Bcl-2 open reading frame. Seven transfectants were individually isolated, and their level of Bcl-2 expression was assessed by western blotting (Fig. 2A) . Of these seven clones, the "P2" clone expressed the most Bcl-2, and therefore we chose it for use in further experiments and renamed it Bcl-2(P2).
We next explored the cellular localization of the Bcl-2 protein expressed in Bcl-2(P2) cells using in vitro cell fractionation (Fig. 2B ) and immunofluorescence microscopy (Fig.  2C) .
Intact NG108-15 cells, Bcl-2(P2) cells, and vector (pCAGGS)-transfected NG108-15 cells were harvested, and the mitochondrial and cytosolic fractions were separated. Western blots showed that the human Bcl-2 protein was expressed and localized to the mitochondrial fraction of only the Bcl-2(P2) cells (Fig. 2B, lane 2) . We also detected a smaller amount of the Bcl-2 protein in the cytosolic fraction of the Bcl-2(P2) cells (Fig. 2B, lane 5) , which may represent over-expressed human Bcl-2 in the endoplasmic reticulum, as was previously reported by Krajewski et al. 36) In the same experiment, the intrinsic mouse Bcl-2 expression was also examined using an anti-mouse Bcl-2 antibody, and we confirmed that the intrinsic mouse Bcl-2 protein was mostly localized to the mitochondrial fraction.
To obtain further evidence that Bcl-2 expression was predominantly in the mitochondria in the Bcl-2(P2) cells, we performed immunofluorescence microscopy using the mouse COX4 antibody to label the mitochondria and human antiBcl-2 antibodies (Fig. 2C) . The COX4 labeling appeared as red fluorescent spots scattered throughout the cytoplasm (Fig. 2C-a) ; Bcl-2 labeling appeared as green fluorescent spots distributed ubiquitously in the cytosol, although some more-intense staining was observed in the nuclear membrane and the exo-cytosolic space (Fig. 2C-b) . The pictures of the COX4 and Bcl-2 labeling were merged, and the merged image showed that the Bcl-2 protein was predominantly expressed in the mitochondria of Bcl-2(P2) cells (yellow spots); however, considerable Bcl-2 protein was clearly observed in places other than in the mitochondria (Fig. 2C-c) [36] [37] [38] reported that the Bcl-2 protein is located outside the mitochondrion, and the green spots in the merged picture probably represent the expression of the Bcl-2 protein in the endoplasmic reticulum and nuclear envelope.
The Over-Expressed Bcl-2 Protein Functions Normally as an Anti-apoptotic Protein in Bcl-2(P2) Cells
We previously showed that a different kind of apoptosis was induced by serum-starvation in NG108-15 cells, 29) and here we used this apoptotic system to evaluate the function of the overexpressed Bcl-2 protein as an apoptosis inhibitor in Bcl-2(P2) cells. First, we grew NG108-15 and Bcl-2(P2) cells under serum-starved conditions, and followed their viability for the next five days (Fig. 3A) . The viability of the serum-starved NG108-15 cells diminished slowly, and no viable cells were observed on day 4 of the experiment. In contrast, most of the Bcl-2(P2) cells were viable up to day 3 and 50% were still living on day 4 (Fig. 3A) . Unlike this serum-starvation-induced cell death, we had previously found that Bph-induced cell death progressed rapidly in NG108-15 cells, with the viability reaching zero about 6 to 8 h after the Bph administration. 29) We next looked for DNA ladder formation, which is a characteristic feature of most kinds of apoptosis. A DNA ladder was observed as early as two days after the initiation of serum-starvation in the parental NG108-15 cells. In contrast, the Bcl-2(P2) cells showed almost no DNA-ladder formation during the five days of the experiment (Fig. 3B) .
We further assessed cytochrome c release from the mitochondrial fraction into the cytosol in serum-starved NG108- 15 and Bcl-2(P2) cells (Fig. 3C) . As we expected, time-dependent cytochrome c release was observed in the NG108-15 cells (Fig. 3C) . In contrast, the western blotting data clearly showed that the efflux of cytochrome c was completely inhibited in the Bcl-2(P2) cells.
These results demonstrated that the serum-starvation-induced apoptosis in NG108-15 cells was an effective positive control, showing that the over-expressed Bcl-2 protein functioned normally in the Bcl-2(P2) cells as an apoptosis inhibitor.
Over-Expression of Bcl-2 in NG108-15 Cells Never Inhibits Bph-Induced Apoptosis Using Bcl-2(P2) cells, we conducted a variety of experiments to test whether the overexpressed Bcl-2 also inhibited the apoptotic events triggered by Bph in the parental cells. The experiments were: a cell viability test, a DNA fragmentation assay, morphological observation of nuclear condensation, FACS analysis for the loss of mitochondrial membrane potential, cytochrome c release from mitochondria, and caspase-9 and -3 activation (Figs.  4A-G) .
We found that the Bcl-2(P2) cells never survived long after the administration of Bph, and that, in fact, the viability curves for the NG108-15 and Bcl-2(P2) cells almost coincided (Fig. 4A) . The DNA fragmentation assay and the morphological observation of nuclear condensation also clearly indicated that the Bcl-2(P2) cells died of apoptosis, as did the parental strain, NG108-15. As early as 2 h after Bph administration, a clear and distinct DNA ladder appeared (Fig. 4B) . In addition, Hoechst 33258 staining indicated obvious and typical nuclear condensation in the Bcl-2(P2) cells at 2 h (Fig. 4C) . These results show that over-expression of Bcl-2 failed to suppress the Bph-induced apoptosis in Bcl-2(P2) cells.
The results shown in Figs. 4D-G elaborated on the finding that the over-expression of Bcl-2 had no effect on the mitochondrial death-signal transduction pathway in this system. The loss of the mitochondrial membrane potential started by 1 h after Bph administration (Fig. 4D) , as it did in the parental NG108-15 cells shown in Fig. 1A . The time-dependent release of cytochrome c from mitochondria (Fig. 4E) followed by the activation of caspases-9, and -3 (Figs. 4F, G) was observed in the Bcl-2(P2) cells, and the results were just as in NG108-15 cells (Fig. 1) . We also repeated the experiments shown in Fig. 4A -G with two other Bcl-2-expressing NG108-15 transfectants, clones "15" and "11" (see Fig. 2A ). The 15 and 11 cells were middle-and low-level Bcl-2 expressors, and their responses to Bph treatment (data not shown) were almost the same as those of the Bcl-2(P2) cells, shown in Figs. 4A-G.
DISCUSSION
Here we studied the apoptotic pathway induced by Bph in the NG108-15 cell line. One characteristic feature of this pathway is its rapidity. Less than 2 h after the administration of Bph to NG108-15 cells, the shape of the cells drastically changes from that of typical neural cells to simple round shapes, and the cells start to float in the medium. Loss of viability occurs almost simultaneously with the drastic morphological changes, as do two other characteristic features, nuclear condensation and DNA-ladder formation. 29, 30) We found a paper reporting ultra-rapid apoptosis, 39) in which cells start dying within 2 min of drug administration. In most cases, however, studies report that drug-induced cell-death 1344 Vol. 27, No. 9 occurs over several days following drug administration. 40, 41) In this context, this Bph-induced apoptosis in NG108-15 cells belongs in the category of "rapid apoptosis," and the mechanism of this particular apoptotic pathway drew our scientific interest.
In our previous study, 30) we reported that caspase-3 activation occurs as a consequence of this particular apoptosis. However, caspase-3 plays a pivotal role in many apoptotic pathways, including the Fas/FasL pathway, the mitochondrial pathway, and the endoplasmic reticulum stress pathway. Therefore, we initiated the present study to identify the signal-transduction pathway of this particular apoptosis.
We focused on the role of three molecules that are important in the major mitochondrial apoptotic pathway: cytochrome c and capsase-9 and -3. We also observed the loss of the mitochondrial membrane potential. Within in 1 h after the administration of Bph, the biochemical events representing the mitochondrial apoptotic route, the loss of the mitochondrial membrane potential, the efflux of cytochrome c from the mitochondria, and the activation of caspase-9 and -3 were all observed in our apoptosis system. The cytochrome c efflux and capase activation that occurred within 1 h after Bph administration were not clearly observed, probably because the amount of the cytochrome c released and caspase-9 activated were too small to be detected by western blot. However, the loss of mitochondrial membrane potential was clearly observed by 1 h after Bph administration and was prolonged until 2 h. These results strongly suggested that the very first event of this apoptotic pathway was the disruption of the mitochondrial membrane function by Bph, and the fol-lowing apoptotic events on the mitochondrial route occurred almost simultaneously. Therefore, it seemed likely that this Bph-induced apoptosis involved the mitochondrial death-signal transduction pathway.
The importance of the mitochondria as a death-signal generator or mediator has been widely accepted. Bcl-2 family proteins, whether pro-or anti-apoptotic, make contact with the mitochondria during apoptotic events. [42] [43] [44] Also, the mitochondrial protein Smac/DIALBO is released from the mitochondria by some apoptotic stimuli, including UV-radiation, but the subsequent caspase activation is blocked by Bcl-2 over-expression. 45) Because we obtained evidence that our Bph-induced apoptosis cascaded from the mitochondria, as shown in Fig. 1 , we examined the contribution of the Bcl-2 protein as a representative anti-apoptotic protein of this apoptotic pathway and established NG108-15 transformant lines that expressed the human Bcl-2 protein (Fig. 2) .
Using one of these lines, Bcl-2(P2), we observed that the human Bcl-2 protein was predominantly in the mitochondria, although there was some expression in the cytosol (probably in the endoplasmic reticulum) and the nuclear membrane (Figs. 2B, 2C-b) . The endogenous mouse Bcl-2 protein was expressed predominantly in the mitochondrial fraction of intact NG108-15 cells, empty vector-transfected NG108-15 cells, and Bcl-2(P2) cells. However, the intrinsic expression of mouse Bcl-2 in the cytosol fraction was very faint and beyond the sensitivity of our western blots. These data indicated that the exogenous human Bcl-2 protein was expressed normally in the NG108-15 cells. However, we needed further confirmation that the overexpressed Bcl-2 protein functioned as an apoptosis inhibitor in the Bcl-2(P2) cells. For this purpose, we exploited another apoptotic pathway in NG108-15 cells that is induced by serum-starvation. The viability curve of Bcl-2(P2) cells, the result of the DNA-ladder formation assay in Figs. 3A, 3B, and the cytochrome c efflux data (Fig.  3C ) clearly indicated that the over-expressed Bcl-2 protein functioned normally in Bcl-2(P2).
Apoptotic pathways are diverse, and include rare forms such as apoptosis without DNA-ladder formation, 46) caspaseindependent apoptosis, 47) and Bcl-2 independent apoptosis. 48) Contrary to our expectations, we observed that the over-expressed human Bcl-2 did not rescue the Bph-induced apoptosis in Bcl-2(P2) cells (Fig. 4) . Rather, all the apoptotic events tested were identical in the Bcl-2(P2) cells and the parental NG108-15 cells. Taken together, these results lead us to conclude that the Bph-induced apoptotic pathway is routed through the mitochondria, but does not respond to Bcl-2 over-expression. In this report, we have presented an unusual mitochondrial apoptotic pathway. The most prominent feature of this particular apoptosis is that some unknown function of Bph cancelled the anti-apoptotic activity of Bcl-2. This may be owing to some physico-chemical characteristic of Bph, because Bph is a hydrophobic compound and easily passes through the double lipid layers of biomembranes. Even if this is true, there is another question that remains: How does Bph disrupt the function of Bcl-2 as an anti-apoptotic protein in the mitochondria? Thus, we need to investigate the possibility that proteins on the mitochondrial outer membrane interact with Bph and transduce its apoptotic signal. Otherwise, it is difficult to explain how Bph could pass through the cell membranes without causing problems, and damage only the mitochondrial membrane. Further study based on a proteome profiling system might help to identify the other players in this new apoptotic pathway.
